Adinath Bio-Labs Ltd
Adinath Bio-Labs is an India-based company, which is engaged in trading in agricultural commodities and its allied products, and also dealing in other concern activities.
- Market Cap ₹ 6.62 Cr.
- Current Price ₹ 0.30
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 0.12
- Dividend Yield 0.00 %
- ROCE -11.6 %
- ROE -11.6 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -13.2% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.82 | 32.50 | 56.45 | 42.17 | 42.85 | 1.00 | 1.35 | 0.81 | 0.56 | 0.05 | 0.00 | 0.00 | |
| 20.10 | 30.30 | 55.42 | 41.09 | 41.89 | 0.73 | 0.97 | 0.73 | 0.42 | 1.83 | 0.55 | 0.53 | |
| Operating Profit | 1.72 | 2.20 | 1.03 | 1.08 | 0.96 | 0.27 | 0.38 | 0.08 | 0.14 | -1.78 | -0.55 | -0.53 |
| OPM % | 7.88% | 6.77% | 1.82% | 2.56% | 2.24% | 27.00% | 28.15% | 9.88% | 25.00% | -3,560.00% | ||
| 0.09 | 0.09 | 0.23 | 0.18 | 0.13 | 0.16 | 0.07 | 0.38 | 0.01 | -4.43 | -1.96 | -2.88 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Depreciation | 0.31 | 0.33 | 0.39 | 0.56 | 0.40 | 0.29 | 0.28 | 0.16 | 0.11 | 0.09 | 0.01 | 0.01 |
| Profit before tax | 1.50 | 1.96 | 0.87 | 0.70 | 0.69 | 0.14 | 0.17 | 0.30 | 0.04 | -6.30 | -2.52 | -3.43 |
| Tax % | 34.67% | 3.06% | 0.00% | 2.86% | 0.00% | 0.00% | -5.88% | 53.33% | 25.00% | 11.59% | -0.79% | 0.00% |
| 0.98 | 1.90 | 0.87 | 0.68 | 0.70 | 0.14 | 0.17 | 0.14 | 0.02 | -7.03 | -2.51 | -3.42 | |
| EPS in Rs | 0.04 | 0.09 | 0.04 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | -0.32 | -0.11 | -0.15 |
| Dividend Payout % | 67.56% | 69.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | -13% |
| Last Year: | -12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 |
| Reserves | 4.37 | 4.72 | 5.59 | 6.27 | 6.97 | 7.11 | 7.08 | 7.23 | -6.44 | -13.47 | -15.97 | -19.40 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.38 | 1.90 | 0.27 | 0.18 | 0.16 | 0.14 | 0.17 | 0.19 | 0.19 | 0.95 | 0.86 | 0.87 | |
| Total Liabilities | 27.82 | 28.69 | 27.93 | 28.52 | 29.20 | 29.32 | 29.32 | 29.49 | 15.82 | 9.55 | 6.96 | 3.54 |
| 3.25 | 3.53 | 2.01 | 1.86 | 1.47 | 1.18 | 0.71 | 0.56 | 0.44 | 0.26 | 0.02 | 0.02 | |
| CWIP | 1.86 | 2.22 | 2.27 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 0.00 | 0.00 | 0.00 |
| Investments | 1.27 | 1.27 | 1.27 | 0.56 | 0.56 | 2.96 | 2.96 | 0.56 | 0.54 | 0.03 | 0.03 | 0.03 |
| 21.44 | 21.67 | 22.38 | 24.23 | 25.30 | 23.31 | 23.78 | 26.50 | 12.97 | 9.26 | 6.91 | 3.49 | |
| Total Assets | 27.82 | 28.69 | 27.93 | 28.52 | 29.20 | 29.32 | 29.32 | 29.49 | 15.82 | 9.55 | 6.96 | 3.54 |
Cash Flows
Figures in Rs. Crores
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.13 | 1.05 | -1.41 | -0.92 | -0.13 | -0.06 | -0.13 | -2.60 | 0.12 | -0.54 | -0.01 | -0.03 | |
| 0.14 | -0.88 | 1.31 | 0.89 | 0.13 | 0.13 | 0.07 | 2.58 | -0.17 | 0.52 | 0.02 | 0.03 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.01 | 0.17 | -0.10 | -0.03 | 0.00 | 0.07 | -0.06 | -0.02 | -0.05 | -0.02 | 0.01 | 0.00 |
| Free Cash Flow | -0.13 | 0.09 | -0.33 | -0.92 | -0.13 | -2.46 | -0.13 | -2.61 | 0.12 | -0.44 | -0.01 | -0.03 |
| CFO/OP | 23% | 71% | -131% | -84% | -14% | -22% | -34% | -3,112% | 86% | 30% | 2% | 6% |
Ratios
Figures in Rs. Crores
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 124.45 | 88.61 | 47.14 | 75.04 | 66.70 | 2,562.30 | 121.67 | 279.38 | 404.11 | 4,526.00 | ||
| Inventory Days | 113.26 | 77.60 | 21.52 | 28.51 | 28.77 | 0.00 | ||||||
| Days Payable | 0.37 | 2.35 | 1.00 | 0.45 | 0.27 | |||||||
| Cash Conversion Cycle | 237.35 | 163.86 | 67.65 | 103.10 | 95.20 | 2,562.30 | 121.67 | 279.38 | 404.11 | 4,526.00 | ||
| Working Capital Days | 335.06 | 219.67 | 69.19 | 101.53 | 93.61 | 3,701.10 | 83.81 | 198.27 | 1,088.48 | 2,190.00 | ||
| ROCE % | 5.69% | 7.36% | 3.20% | 2.50% | 2.41% | 0.48% | 0.58% | 0.38% | 0.18% | -11.39% | -7.21% | -11.63% |
Documents
Announcements
- Standalone Financial Results, Limited Review Report for December 31, 2016 10 Feb 2017
- Board Meeting Intimation for Results & Closure of Trading Window 30 Jan 2017
- Shareholding for the Period Ended December 31, 2016 18 Jan 2017
- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016 13 Jan 2017
-
Statement of Deviation or Variation
12 Jan 2017 - Adinath Bio-Labs Ltd has submitted to BSE the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended …